荣昌生物(09995.HK)2025年扭亏为盈 净利润约7.09亿元

Group 1 - The company Rongchang Bio (09995.HK) reported a total revenue of approximately 3.251 billion RMB for 2025, representing a year-on-year increase of 89.36% [1] - The net profit attributable to the parent company's owners is approximately 709 million RMB, a significant recovery from a loss of about 1.468 billion RMB in the same period of 2024 [1] - The basic earnings per share is reported at 1.29 RMB [1]